CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 123 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2023. The put-call ratio across all filers is 1.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,086,522 | -46.3% | 49,772 | -21.8% | 0.00% | -100.0% |
| Q2 2023 | $2,022,767 | +36.2% | 63,629 | +4.5% | 0.00% | – |
| Q1 2023 | $1,484,619 | +195.7% | 60,870 | +282.4% | 0.00% | – |
| Q4 2022 | $501,991 | +780.7% | 15,916 | +691.4% | 0.00% | – |
| Q3 2022 | $57,000 | -6.6% | 2,011 | -12.3% | 0.00% | – |
| Q2 2022 | $61,000 | -82.0% | 2,294 | -76.3% | 0.00% | – |
| Q1 2022 | $339,000 | -55.5% | 9,688 | -58.7% | 0.00% | – |
| Q4 2021 | $761,000 | -45.0% | 23,481 | -49.9% | 0.00% | – |
| Q3 2021 | $1,383,000 | – | 46,869 | +4686800.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 1 | -99.6% | 0.00% | – |
| Q4 2020 | $4,000 | – | 240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,965,701,000 | 23.51% |
| Affinity Asset Advisors, LLC | 225,000 | $7,295,000 | 2.65% |
| Perceptive Advisors | 10,173,454 | $329,822,000 | 2.54% |
| Artal Group S.A. | 1,500,000 | $48,630,000 | 1.32% |
| Rock Springs Capital Management LP | 1,648,435 | $53,442,000 | 1.24% |
| RTW INVESTMENTS, LP | 666,666 | $21,613,000 | 0.32% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 8,900 | $289,000 | 0.28% |
| EAM Investors, LLC | 39,907 | $1,294,000 | 0.21% |
| FEDERATED HERMES, INC. | 3,113,333 | $100,934,000 | 0.19% |
| Alkeon Capital Management | 1,909,035 | $61,891,000 | 0.12% |